Low-dose computed-tomography lung cancer screening: the first European recommendations from the European Society of Radiology and European Respiratory Society.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis.Journal of medical screening · 2023
   Pooled it
2. Swiss Pilot Low-Dose CT Lung Cancer Screening Study: First Baseline Screening Results.Journal of clinical medicine · 2023
   Article
3. Risk factors assessment and risk prediction models in lung cancer screening candidates.Annals of translational medicine · 2016
   Review

Corrections and comments

• Comment on
  ESR/ERS white paper on lung cancer screening.2015

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as